![Jeff Szekeres](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeff Szekeres
Directeur/Membre du Conseil chez Andelyn Biosciences
Postes actifs de Jeff Szekeres
Sociétés | Poste | Début | Fin |
---|---|---|---|
Andelyn Biosciences
![]() Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jeff Szekeres
Anciens postes connus de Jeff Szekeres
Sociétés | Poste | Début | Fin |
---|---|---|---|
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Directeur/Membre du Conseil | - | - |
Eurofins Genomics Blue Heron LLC
![]() Eurofins Genomics Blue Heron LLC Miscellaneous Commercial ServicesCommercial Services Eurofins Genomics Blue Heron LLC engages in the development of accurate gene synthesis platform for the production of genes and gene variants for use in expression analysis. Its services include GeneMaker technology, vector synthesis & custom cloning, plasmid preparation, and variant library. The company was founded by John Mulligan in 1999 and is headquartered in Bothell, WA. | Directeur/Membre du Conseil | 14/05/2010 | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 3 |
Sectorielle
Commercial Services | 2 |
Electronic Technology | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Eurofins Genomics Blue Heron LLC
![]() Eurofins Genomics Blue Heron LLC Miscellaneous Commercial ServicesCommercial Services Eurofins Genomics Blue Heron LLC engages in the development of accurate gene synthesis platform for the production of genes and gene variants for use in expression analysis. Its services include GeneMaker technology, vector synthesis & custom cloning, plasmid preparation, and variant library. The company was founded by John Mulligan in 1999 and is headquartered in Bothell, WA. | Commercial Services |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
Andelyn Biosciences
![]() Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Health Technology |
- Bourse
- Insiders
- Jeff Szekeres
- Expérience